Sean Edward Lawler, Ph.D.
This page shows the publications co-authored by Sean Lawler and Gilles Berger.
Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy. Trends Mol Med. 2019 05; 25(5):412-427.
Novel non-nucleotidic STING agonists for cancer immunotherapy. Future Med Chem. 2018 12; 10(24):2767-2769.
Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy. Pharm Pat Anal. 2019 07; 8(4):87-90.
Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett. 2018 03 01; 416:138-148.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.